Cargando…
Obesity and cancer, a case for insulin signaling
Obesity is a worldwide epidemic, with the number of overweight and obese individuals climbing from just over 500 million in 2008 to 1.9 billion in 2014. Type 2 diabetes (T2D), cardiovascular disease and non-alcoholic fatty liver disease have long been associated with the obese state, whereas cancer...
Autores principales: | Poloz, Y, Stambolic, V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720912/ https://www.ncbi.nlm.nih.gov/pubmed/26720346 http://dx.doi.org/10.1038/cddis.2015.381 |
Ejemplares similares
-
Lysophosphatidic Acid Signaling in Obesity and Insulin Resistance
por: D’Souza, Kenneth, et al.
Publicado: (2018) -
Dietary Flavonoids and Insulin Signaling in Diabetes and Obesity
por: Martín, María Ángeles, et al.
Publicado: (2021) -
The Role of the Nrf2 Signaling in Obesity and Insulin Resistance
por: Li, Shiri, et al.
Publicado: (2020) -
The Role of JNk Signaling Pathway in Obesity-Driven Insulin Resistance
por: Feng, Jia, et al.
Publicado: (2020) -
Nek family of kinases in cell cycle, checkpoint control and cancer
por: Moniz, Larissa, et al.
Publicado: (2011)